Including Aβ42/Aβ40 ratio and GFAP level improved the specificity for identifying individuals with evidence of cognitive impairment who progressed to clinically-diagnosed DAT, compared to using only MMSE score and basic demographics. Here, GFAP is linked to Cognitive impairment.